{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:18:16Z","timestamp":1791987496971,"version":"4.4.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.soncn.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T10:32:51Z","timestamp":1499855571000},"page":"299-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life"],"prefix":"10.1016","volume":"33","author":[{"given":"Tracy A.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2017.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European myeloma network guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.soncn.2017.05.006_bib0015","author":"Ferlay"},{"key":"10.1016\/j.soncn.2017.05.006_bib0020","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","article-title":"Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.soncn.2017.05.006_bib0025","author":"National Comprehensive Cancer Network (NCCN)"},{"key":"10.1016\/j.soncn.2017.05.006_bib0030","author":"Bird"},{"key":"10.1016\/j.soncn.2017.05.006_bib0035","first-page":"599","article-title":"Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey","volume":"21","author":"Acaster","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"On behalf of the haematology-oncology Task Force of the British committee for standards in haemtology and UK myeloma forum. Guidelines for supportive care in multiple myeloma","volume":"54","author":"Snowden","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ejh.12012","article-title":"What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools","volume":"89","author":"Osborne","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","article-title":"Health related quality of life in a nationally representative sample of haematological patients","volume":"83","author":"Johnsen","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","article-title":"Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10\u2009yr after diagnosis: results from a population-based study using the PROFILES registry","volume":"89","author":"Mols","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0060","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1002\/cncr.28340","article-title":"Treatment trade-offs in myeloma","volume":"15","author":"Burnette","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0065","first-page":"417","article-title":"Effect of general symptom level, specific adverse events, treatment patterns and patient characteristics on health-related quality of life in patients with multiple myeloma: results of European, multicentre cohort study","volume":"22","author":"Jordan","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/1471-2407-14-496","article-title":"Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life","volume":"14","author":"Osborne","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0075","first-page":"2789","article-title":"Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life","volume":"23","author":"Baz","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12885-016-2410-2","article-title":"The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study","volume":"16","author":"Ramsenthaler","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bjh.14058","article-title":"The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials","volume":"174","author":"Robinson","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00277-014-2264-0","article-title":"Elderly multiple myeloma patients experience less deteriation in health-related quality of life than younger patients compared to normative populations: a study from population-based PROFILES registry","volume":"94","author":"Van der Poel","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0095","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centred outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijnurstu.2006.07.016","article-title":"\u201cWhat's in a name?\u201d The indiscriminate use of the \u201cQuality of life\u201d label, and the need to bring about clarity in conceptualizations","volume":"44","author":"Dijkers","year":"2007","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.soncn.2017.05.006_bib0105","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1008996223999","article-title":"Recommendations on health-related quality of life research to support labelling and promotion claims in the United States","volume":"9","author":"Revicki","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0110","series-title":"The quality of life: the missing measurement in health care","author":"Fallowfield","year":"1990"},{"key":"10.1016\/j.soncn.2017.05.006_bib0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1586\/14737167.2013.838024","article-title":"Conceptual, classification or causal: models of health status and health-related quality of life","volume":"13","author":"Costa","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"4","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2017.05.006_bib0125","first-page":"65132","article-title":"Guidance for industry on patient-reported outcome measures: use in medical product development to support labelling claims. US department of health & human support food & drug administration","volume":"74","author":"Food and Drug Administration","year":"2009","journal-title":"Fed Regist"},{"key":"10.1016\/j.soncn.2017.05.006_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11136-015-1099-z","article-title":"International society for quality of life research commentary on the draft European medicines agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies","volume":"25","author":"Kyte","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0135","series-title":"Reflection paper on the use of patient reported outcome (PRO) measures in oncology studies [Draft]","author":"EMA","year":"2014"},{"key":"10.1016\/j.soncn.2017.05.006_bib0140","author":"Chen"},{"key":"10.1016\/j.soncn.2017.05.006_bib0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2141.1996.352889.x","article-title":"Measurement of health-related quality of life in multiple myeloma","volume":"92","author":"Wisloff","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0150","first-page":"1","article-title":"Self-reported quality of life and symptom burden in ambulatory patients with multiple myeloma on disease modifying treatment","author":"Kiely","year":"2016","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.soncn.2017.05.006_bib0155","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14514","article-title":"Guidelines for screening and management of late and long-term consequences of myeloma and its treatment","author":"Snowden","year":"2017","journal-title":"Br J Haematol"},{"issue":"suppl","key":"10.1016\/j.soncn.2017.05.006_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1188\/08.CJON.S1.9-12","article-title":"Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board","volume":"12","author":"Bertolotti","year":"2008","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2017.05.006_bib0165","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/leu.2013.185","article-title":"Review of health-related quality of life data in multiple myeloma patients treated with novel agents","volume":"27","author":"Sonneveld","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.soncn.2017.05.006_bib0170","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1182\/blood-2014-03-558981","article-title":"Symptom burden in hematologic malignancies","volume":"123","author":"Cleeland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.soncn.2017.05.006_bib0175","first-page":"2615","article-title":"Holistic needs assessment in advanced, intensively treated multiple myeloma patients","volume":"22","author":"Boland","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","article-title":"Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life","volume":"46","author":"Boland","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.soncn.2017.05.006_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/MO:18:1:65","article-title":"Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support","volume":"18","author":"Gulbrandsen","year":"2001","journal-title":"Med Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbmt.2008.09.023","article-title":"Changes in quality of life and psychosocial adjustment amongst multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation","volume":"15","author":"Sherman","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.soncn.2017.05.006_bib0195","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3109\/10428194.2013.847933","article-title":"Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged \u226565 years treated with melphalan, prednisolone and lenalidomide followed by lenalidomide maintenance: results of a randomised trial","volume":"55","author":"Dimopoulos","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.soncn.2017.05.006_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-8-79","article-title":"Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma","volume":"8","author":"Kvam","year":"2010","journal-title":"Qual Life Outcomes"},{"key":"10.1016\/j.soncn.2017.05.006_bib0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pon.1710","article-title":"Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners","volume":"20","author":"Molassiotis","year":"2011","journal-title":"Psychooncology"},{"key":"10.1016\/j.soncn.2017.05.006_bib0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0609.2008.01126.x","article-title":"Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma","volume":"81","author":"Strasser-Weippl","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0215","first-page":"101","article-title":"Living with multiple myeloma: experiences of patients and their informal caregivers","volume":"19","author":"Molassiotis","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0220","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/jan.12430","article-title":"The work of living with a rare cancer: multiple myeloma","volume":"70","author":"Stephens","year":"2014","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.soncn.2017.05.006_bib0225","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients' vs clinicians: relationships with clinical outcomes","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soncn.2017.05.006_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JOP.2014.001423","article-title":"Patient-reported outcome performance measures in oncology","volume":"10","author":"Basch","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.soncn.2017.05.006_bib0235","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","article-title":"Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations","volume":"21","author":"Snyder","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0240","author":"Aaronson"},{"key":"10.1016\/j.soncn.2017.05.006_bib0245","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","article-title":"Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors","volume":"26","author":"Howell","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2016.08.024","article-title":"The use of EORTC measures in daily clinical practice: a synopsis of a newly developed manual","volume":"68","author":"Wintner","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11136-008-9430-6","article-title":"The applications of PROs in clinical practice: what are they, do they work, and why?","volume":"11","author":"Greenhalgh","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0149-2918(96)80054-3","article-title":"Evaluating quality of life and health status instruments: development of scientific review criteria","volume":"18","author":"Lohr","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/j.soncn.2017.05.006_bib0265","author":"Novik"},{"key":"10.1016\/j.soncn.2017.05.006_bib0270","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s11136-016-1278-6","article-title":"The use and impact of quality of life assessment tools in clinical care settings for cancer patients, with a particular emphasis on brain cancer: insights from a systematic review and stakeholder consultation","volume":"25","author":"King","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLC-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soncn.2017.05.006_bib0280","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01206.x","article-title":"Development of an EORTC questionnaire module to be used in health-related quality of life assessment for patients with multiple myeloma","volume":"104","author":"Stead","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0285","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","article-title":"An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma","volume":"43","author":"Cocks","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0290","article-title":"The utility of the new instrument for comprehensive symptom profile assessment in patients with multiple myeloma","volume":"116","author":"Novik","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.soncn.2017.05.006_bib0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-6-13","article-title":"Validation of the M.D. Anderson Symptom Inventory multiple myeloma module","volume":"6","author":"Jones","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0300","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-015-1261-6","article-title":"Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)","volume":"15","author":"Osborne","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0305","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy (FACT) scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/cncr.29104","article-title":"Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care","volume":"121","author":"Wagner","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0315","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy (New York)"},{"key":"10.1016\/j.soncn.2017.05.006_bib0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.soncn.2017.05.006_bib0325","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.soncn.2017.05.006_bib0330","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.soncn.2017.05.006_bib0335","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"De Souza","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0340","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0345","series-title":"The Guide to Clinical Preventive Services 2010\u20132011 Recommendations of the U.S. Preventive Task Force","author":"US Preventive Services Task Force","year":"2010"},{"key":"10.1016\/j.soncn.2017.05.006_bib0350","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cam4.716","article-title":"Lack of health maintenance examinations and risk in myeloma patients","volume":"5","author":"Tariman","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.soncn.2017.05.006_bib0355","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0360","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0365","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0370","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0375","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s11136-013-0390-0","article-title":"Does providing feedback on patient-reported outcomes to healthcare professional result in better outcomes for patients? A systematic review","volume":"22","author":"Boyce","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0380","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0385","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.ejca.2010.04.030","article-title":"Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial","volume":"46","author":"Velikova","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2017.05.006_bib0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pec.2005.10.005","article-title":"Patient participation in the consultation process: a structured review of intervention strategies","volume":"63","author":"Haywood","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.soncn.2017.05.006_bib0395","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soncn.2017.05.006_bib0400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2014.11.071","article-title":"Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic","volume":"136","author":"Gilbert","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"suppl","key":"10.1016\/j.soncn.2017.05.006_bib0405","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1200\/jco.2015.33.15_suppl.9520","article-title":"Comparison between clinician-and patient-reporting of baseline and post-baseline symptomatic toxicities in cancer cooperative group clinical trials (NCCTG N0591 [Alliance]","volume":"33","author":"Atkinson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0410","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anti-cancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0415","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2005.04.275","article-title":"Patient online self-reporting of toxicity symptoms during chemotherapy","volume":"23","author":"Basch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0420","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1524-4733.2007.00231.x","article-title":"Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review","volume":"11","author":"Gwaltney","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.soncn.2017.05.006_bib0425","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02841860410029357","article-title":"Proxy ratings of patient quality of life: factors related to patient-proxy agreement","volume":"43","author":"Von Essen","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0430","first-page":"163","article-title":"Does routine assessment and real-time feedback improve cancer patients' psychosocial well-being?","volume":"15","author":"Boyes","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.soncn.2017.05.006_bib0435","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpainsymman.2009.06.015","article-title":"Implementation of computer-based quality of life monitoring in brain tumour outpatients in routine clinical practice","volume":"39","author":"Erharter","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.soncn.2017.05.006_bib0440","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2012.47.6804","article-title":"Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy","volume":"31","author":"Judson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0445","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpainsymman.2010.01.017","article-title":"Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients","volume":"40","author":"Abernathy","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.soncn.2017.05.006_bib0450","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpainsymman.2011.04.028","article-title":"Quality improvement in cancer symptom assessment and control: the Provincial Palliative Care Integration Project (PPCIP)","volume":"43","author":"Gilbert","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.soncn.2017.05.006_bib0455","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient reported outcomes in randomised trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2017.05.006_bib0460","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eururo.2015.06.007","article-title":"Development of a standardised set of patient-centred outcomes for advanced prostate cancer: an international effort for a unified approach","volume":"68","author":"Morgans","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0465","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.blre.2011.03.005","article-title":"Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?","volume":"25","author":"Palumbo","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.soncn.2017.05.006_bib0470","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5737\/1181912x181614","article-title":"Supportive care framework","volume":"18","author":"Fitch","year":"2008","journal-title":"Can Oncol Nurs J"},{"key":"10.1016\/j.soncn.2017.05.006_bib0475","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jclinepi.2006.10.006","article-title":"Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis","volume":"60","author":"Viala","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.soncn.2017.05.006_bib0480","series-title":"Improving Palliative Care for Cancer","author":"Institute of Medicine","year":"2000"},{"key":"10.1016\/j.soncn.2017.05.006_bib0485","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejon.2004.07.004","article-title":"Creating a culture of compassion: developing supportive care for people with cancer","volume":"8","author":"Richardson","year":"2004","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.soncn.2017.05.006_bib0490","series-title":"Providing supportive care for individuals living with cancer","author":"Fitch","year":"1994"},{"key":"10.1016\/j.soncn.2017.05.006_bib0495","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-015-1261-6","article-title":"Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)","volume":"15","author":"Osborne","year":"2015","journal-title":"BMC Cancer"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208117300414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208117300414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:33:11Z","timestamp":1760081591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208117300414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0749208117300414"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2017.05.006","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}